Prof. Dr. rer. nat. Tanja Schneider
Head of Department
Research
Tanja Schneider studied biology in Bonn, Germany, specialized in microbiology and obtained her PhD in 2004. Following a postdoctoral training at the Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, she joined industry from 2011 until 2012. During that time she worked at the Peptide and Cell Discovery Department at Novozymes A/S, Denmark in the course of a Marie Curie Actions fellowship. Returning to Germany, she became a junior research group leader within the German Center for Infection Research (DZIF). In 2014 she completed her habilitation in Medical-Pharmaceutical Microbiology and was appointed Professor of Pharmaceutical Microbiology at the University of Bonn in 2015.
Prof. Dr. rer. nat. Tanja Schneider
Head of Department
Meckenheimer Allee 168
53115 Bonn
Institut für Pharmazeutische Mikrobiologie
Universitätsklinikum Bonn
Universität Bonn
CV
2015 Professor (W2) for Pharmaceutical Microbiology, University of Bonn
2012-2014 Junior research group leader; “Antibiotic mechanisms”; German Center for Infection Research (DZIF), Bonn
2011-2012 Novozymes A/S, Kopenhagen, Denmark
2008-2011 Principal investigator at the University of Bonn; DFG-project; FOR 854 „Post-genomic strategies for new antibiotic drugs and targets
2005-2008 Postdoc at the University of Bonn
2002-2004 Graduate PhD student at the University of Bonn
2014 Habilitation (venia legendi) in Medical and Pharmaceutical Microbiology; University of Bonn
2004 Ph.D., Biology, specialized in microbiology, University of Bonn
Ph.D. thesis at the Institute of Medical Microbiology and Immunology, University of Bonn, under the direction of Prof. Dr. Hans Georg Sahl
2001 Diploma in biology, University of Bonn
diploma thesis at the Institute of Medical Microbiology and Immunology, University of Bonn
1995-2001Studies of biology at the Rheinische Friedrich-Wilhelms-University of Bonn
2015 Member of the PEG
2010 Member of the "Robert-Koch Stiftung e.V."
2010 Member of the „Deutsche Gesellschaft für Hygiene und Mikrobiologie“ (DGHM), Germany
2007 Member of the American Society for Microbiology (ASM)
2000 Member of the „Vereinigung für Allgemeine und Angewandte Mikrobiologie (VAAM)“, Germany
Funding
German Centre for Infection Research (DZIF), TTU Novel Antibiotics
TRR261 - antibiotic CellMAP-Cellular mechanisms of antibiotic action and production
National Institute of health (NIH), “Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment“
Maria-von-Linden Programme, University of Bonn
Honours and Awards
Wolfgang-Stille Award of the Paul-Ehrlich-Society for Chemotherapy
year
2016
Invited Speach, “G7 Dialogue Forum-Science Conference”, German National Academy of Science, Leopoldina
year
2015